http://biz.yahoo.com/ic/news/512.htmlThe latest news on the Drugs - Generic industry from Yahoo! Financeen-usFri, 5 Sep 2008 17:48:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/080905/0431147.htmlyahoo_finance/2904172875Fri, 5 Sep 2008 17:48:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=134fih97h/*http://www.fool.com/investing/high-growth/2008/09/04/tapping-the-brakes-on-the-teva-barr-deal.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3383970090Thu, 4 Sep 2008 19:05:51 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/080903/0430394.htmlyahoo_finance/3601764658Wed, 3 Sep 2008 20:47:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080903/teva_barr_buyout.html?.v=1Federal regulators are seeking additional information about Teva's plan to buy generic drug rival Barr Pharmaceuticals. The $7.5 billion deal, announced in July, would cement Israel-based Teva's role as the largest generic drugmaker in the world.yahoo_finance/896742346Wed, 3 Sep 2008 19:02:35 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11iiumket/*http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b0EACE6CF-42A1-4A45-9890-F9E283AC7A81%7d&siteid=yhoof2yahoo_finance/1410944268Wed, 3 Sep 2008 18:10:19 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080903/20080903006298.html?.v=1JERUSALEM & MONTVALE, N.J.----Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced today that, as expected, each party has received a request for additional information from the U.S.yahoo_finance/829027310Wed, 3 Sep 2008 18:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080903/20080903006062.html?.v=1AMITYVILLE, N.Y.----Hi-Tech Pharmacal Co., Inc. announced that the Company will release results for its first quarter of Fiscal Year 2009 ended July 31, 2008, prior to the market opening on Monday September 8, 2008 and will hold a conference call to discuss its financial results at 10 a.m.yahoo_finance/2633393503Wed, 3 Sep 2008 15:17:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/forbes/rss/SIG=12ths7aug/*http://www.forbes.com/2008/08/29/mylan-barr-closer-markets-equity-cx_lal_0829markets25.html?partner=yahootixyahoo_finance/4262650403Fri, 29 Aug 2008 20:40:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/forbes/rss/SIG=12tnscrbd/*http://www.forbes.com/2008/08/29/mylan-barr-update-markets-equity-cx_lal_0829markets19.html?partner=yahootixyahoo_finance/1154402352Fri, 29 Aug 2008 18:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/forbes/rss/SIG=12um9mfkv/*http://www.forbes.com/2008/08/29/mylan-barr-generic-markets-equity-cx_lal_0829markets15.html?partner=yahootixyahoo_finance/298904511Fri, 29 Aug 2008 16:57:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080829/mylan_patent.html?.v=3Mylan Inc. said Friday it is immediately launching a generic version of the Alzheimer's disease drug Razadyne after receiving regulatory approval and a favorable court ruling.yahoo_finance/1394080374Fri, 29 Aug 2008 14:55:43 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12eg28h76/*http://pittsburgh.bizjournals.com/pittsburgh/stories/2008/08/25/daily29.html?ana=yfcpcyahoo_finance/522482445Fri, 29 Aug 2008 14:25:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080829/nef011.html?.v=70Mylan Inc. today announced that its subsidiary Alphapharm Pty Limited won a favorable decision in patent litigation against it and Barr Laboratories Inc. relating to Galantamine Tablets, USP, the generic version of Ortho-McNeil's Razadyne® Tablets, 4 mg, 8 mg and 12 mg.yahoo_finance/394206835Fri, 29 Aug 2008 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11pamkidh/*http://online.wsj.com/article/SB121996948904981805.html?mod=yahoo_hs&ru=yahooyahoo_finance/4047395555Fri, 29 Aug 2008 00:54:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11thqbd2i/*http://online.barrons.com/article/SB121987664783177755.html?mod=yahoobarrons&ru=yahooyahoo_finance/2040239165Thu, 28 Aug 2008 17:41:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080828/hi_tech_pharmacal_product.html?.v=1Generic drug developer and nutritional products company Hi-Tech Pharmacal Co. said Thursday it asked a district court to rule that it is eligible for 180 days of market exclusivity for a generic version of Merck's glaucoma treatment Cosopt.yahoo_finance/2322603549Thu, 28 Aug 2008 16:57:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080828/nyth058.html?.v=101Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S. Food & Drug Administration to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne® , 4 mg, 8 mg and 12 mg tablets.yahoo_finance/3079485846Thu, 28 Aug 2008 16:18:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080828/barr_razadyne.html?.v=1Barr Pharmaceuticals Inc. said Thursday a U.S. District Court voided a patent on the drug Razadyne, a drug used to treat dementia related to Alzheimer's disease, which would allow Barr to sell a generic version.yahoo_finance/1968093133Thu, 28 Aug 2008 15:56:19 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080828/20080828005658.html?.v=1AMITYVILLE, N.Y.----Hi-Tech Pharmacal Co., Inc. announced that the Company filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration requesting a declaratory judgment related to Hi-Tech's Abbreviated New Drug Application for dorzolamide and timolol ophthalmic solution, the generic for Merck's Cosopt®.yahoo_finance/4107603387Thu, 28 Aug 2008 15:46:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080828/nyth030.html?.v=101Barr Pharmaceuticals, Inc. today announced that the U.S. District Court for the District of Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of U.S.yahoo_finance/1186074348Thu, 28 Aug 2008 12:48:00 Etc/GMT